LIPELLA PHARMACEUTICALS INC Contracts & Agreements
41 Contracts & Agreements
- Business Finance (20 contracts)
- Business Operations (1)
- Human Resources (12)
- Real Estate (4)
- Uncategorized (4)
- Form of Pre-Funded Warrant (Filed With SEC on August 1, 2024)
- Form of Placement Agent Warrant (Filed With SEC on August 1, 2024)
- Form of Securities Purchase Agreement, dated as of July 31, 2024, by and between the Company and the Investor (Filed With SEC on August 1, 2024)
- Engagement Agreement, dated July 31, 2024, by and between the Company and the Placement Agent (Filed With SEC on August 1, 2024)
- Suite 504 Lease Agreement, by and between the Company and Bridgeway, effective January 1, 2024 (Filed With SEC on May 9, 2024)
- Affiliate Stock Purchase Agreement, dated as of March 13, 2024, by and between the Company and Jonathan Kaufman (Filed With SEC on March 15, 2024)
- Affiliate Stock Purchase Agreement, dated as of March 13, 2024, by and between the Company and Michael Chancellor (Filed With SEC on March 15, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on October 26, 2023)
- Form of Warrant (Filed With SEC on October 26, 2023)
- Form of Placement Agent Warrant (Filed With SEC on October 26, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on October 26, 2023)
- Form of Registration Rights Agreement (Filed With SEC on October 26, 2023)
- Amendment No. 1 to the Employment Agreement, dated August 4, 2023, by and between Lipella Pharmaceuticals Inc. and Jonathan Kaufman (Filed With SEC on August 8, 2023)
- Amendment No. 1 to the Employment Agreement, dated August 4, 2023, by and between Lipella Pharmaceuticals Inc. and Michael Chancellor (Filed With SEC on August 8, 2023)
- Lease Agreement made by and between Lipella Pharmaceuticals Inc. and Bridgeway Development Corporation, executed on July 27, 2023 (Filed With SEC on August 2, 2023)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 31, 2023)
- Form of Underwriting Agreement (Filed With SEC on December 13, 2022)
- Form of Underwriting Agreement (Filed With SEC on December 8, 2022)
- Form of Underwriters Warrant (Filed With SEC on December 8, 2022)
- Employment Agreement by and between the Company and Douglas Johnston, entered into on November 9, 2022 and effective as of November 1, 2022 (Filed With SEC on November 28, 2022)
- Lipella Pharmaceuticals Inc. 2008 Stock Incentive Plan (Filed With SEC on November 28, 2022)
- Form of Stock Option Agreement for Lipella Pharmaceuticals Inc. 2008 Stock Incentive Plan (Filed With SEC on November 28, 2022)
- Lipella Pharmaceuticals Inc. 2020 Stock Incentive Plan (Filed With SEC on November 28, 2022)
- Form of Stock Option Agreement for Lipella Pharmaceuticals Inc. 2020 Stock Incentive Plan (Filed With SEC on November 28, 2022)
- Form of Lipella Pharmaceuticals Inc. 2020 Stock Incentive Plan, as amended and restated (Filed With SEC on November 28, 2022)
- Form of Option Agreement for Lipella Pharmaceuticals Inc. Amended and Restated 2020 Stock Incentive Plan (Filed With SEC on November 28, 2022)
- Form of Restricted Stock Unit Agreement for Lipella Pharmaceuticals Inc. Amended and Restated 2020 Stock Incentive Plan (Filed With SEC on November 28, 2022)
- Lease dated June 1, 2019 between Bridgeway Development Corporation and Lipella Pharmaceuticals Inc (Filed With SEC on November 28, 2022)
- Amendment No. 2 to Lease Agreement between Bridgeway Development Corporation and Lipella Pharmaceuticals Inc. dated July 2, 2020 (Filed With SEC on November 28, 2022)
- Shareholders Agreement dated May 26, 2005 between Shareholders of Lipella Pharmaceuticals Inc and Lipella Pharmaceuticals Inc (Filed With SEC on November 28, 2022)
- Note Cancellation and Stock Purchase Agreement between Dr. Michael Chancellor and Lipella Pharmaceuticals Inc (Filed With SEC on November 28, 2022)
- Form of Indemnification Agreement for Lipella Pharmaceuticals Inc (Filed With SEC on November 28, 2022)
- Promissory Note, dated August 21, 2009, by and between Michael Chancellor and Lipella Pharmaceuticals Inc (Filed With SEC on November 28, 2022)
- Promissory Note, dated January 25, 2015, by and between Michael Chancellor and Lipella Pharmaceuticals Inc (Filed With SEC on November 28, 2022)
- Promissory Note, dated November 1, 2022, by and between Jonathan Kaufman and Lipella Pharmaceuticals Inc (Filed With SEC on November 28, 2022)
- Letter Agreement, dated February 9, 2022, by and between Young & Partners LLC and Lipella Pharmaceuticals Inc (Filed With SEC on November 28, 2022)
- Form of Underwriting Agreement (Filed With SEC on October 24, 2022)
- Form of Underwriters Warrant (Filed With SEC on October 24, 2022)
- Employment Agreement by and between the Company and Jonathan Kaufman, effective as of July 17, 2020 (Filed With SEC on July 29, 2022)
- Employment Agreement by and between the Company and Michael Chancellor, effective as of July 17, 2020 (Filed With SEC on July 29, 2022)
- Letter Agreement, dated October 14, 2021, between the Company and Stonewall Finance, LLC (Filed With SEC on July 29, 2022)
